FDA approves Lupin’s generic antibiotic: 3 things to know

Lupin Pharmaceuticals earned Food and Drug Administration approval for its generic doxycycline hyclate tablets, reports Business Standard.

Advertisement

Here are three things to know.

  1. Doxycycline hyclate tablets are intended to treat various bacterial infections.
  1. The tablets may also be used as an adjunctive treatment for severe acne.
  1. Doxycycline hyclate tablets are a generic version of Pfizer’s Vibra-Tabs.

More articles on supply chain:

FDA calls out EpiPen manufacturer for product flaws linked to patient deaths
Facebook promotes ‘clinical trials strategy’ to drugmakers
CMS to replace beneficiary-owned medical equipment damaged by Harvey

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.